Helius Medical Technologies EBIT

Helius Medical Technologies (HSDT) currently reports a EBIT of $-140M as of March 2026. That compares with $-14M in the prior-year period — down 838.7% year over year. That is below the Technology sector average of $12T. Use the charts on this page to explore Helius Medical Technologies's EBIT history and peer comparisons.

Helius Medical Technologies's EBIT decreased from $-14M to $-140M — a 838.7% year-over-year decrease (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Helius Medical Technologies's EBIT of $-140M is lower than the Technology sector average of $12T. That is roughly 100.0% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

Helius Medical Technologies reported $-140M in EBIT as of March 2026. That compares with $-14M in the prior-year period — down 838.7% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current EBIT of $-140M, then check the historical chart for trend and the peer comparison chart for relative positioning. The Technology average is $12T. From there, open related valuation or income-statement pages for Helius Medical Technologies, and consider following HSDT for alerts when major investors trade the stock.